Prognostic markers in nephroblastoma (Wilms' tumor)

Urology

Volumn 65, Issue 6, 2005, Pages 1047-1054

  Ghanem, Mazen A ^b   Van Steenbrugge, Gert J ^a   Nijman, Rien J M ^b   Van Der Kwast, Theodorus H ^b  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CELL ADHESION MOLECULE; CYCLINE; DNA TOPOISOMERASE; EPIDERMAL GROWTH FACTOR; GLYCOPROTEIN; HERMES ANTIGEN; HYALURONIC ACID; INTEGRIN; MIDKINE; MULTIDRUG RESISTANCE PROTEIN; NERVE GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN P53; RENIN; SCLEROPROTEIN; SOMATOMEDIN; TENASCIN; TUMOR MARKER; UNCLASSIFIED DRUG; VASCULOTROPIN; WT1 PROTEIN; WT2 PROTEIN; WT3 PROTEIN;

APOPTOSIS; CANCER STAGING; CARCINOGENESIS; CHROMOSOME 11P; CHROMOSOME DELETION; DNA METHYLATION; DNA MICROARRAY; DNA SEQUENCE; FLOW CYTOMETRY; GENE EXPRESSION; GENE LOCATION; GENE LOCUS; GENE MUTATION; HETEROZYGOSITY; HETEROZYGOSITY LOSS; HOMOZYGOSITY; HUMAN; IMMUNOHISTOCHEMISTRY; MISMATCH REPAIR; MULTIDRUG RESISTANCE; NEPHROBLASTOMA; ONCOGENE; ONCOGENE C MYB; PLASMA RENIN ACTIVITY; PLOIDY; POINT MUTATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; TUMOR SUPPRESSOR GENE;

BIOLOGICAL MARKERS; GENETIC MARKERS; HUMANS; KIDNEY NEOPLASMS; PROGNOSIS; WILMS TUMOR;

EID: 20444431941     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2004.12.005     Document Type: Review

References (49)

1. J. De Kraker, S. Weitzman, P.A. Voute Preoperative strategies in the management of Wilms' tumor Hematol Oncol Clin North Am 9 1995 1275 1285
2. G.J. D'Angio, N. Breslow, J.B. Beckwith Treatment of Wilms' tumor results of the Third National Wilms' tumor study Cancer 64 1989 349 360
3. J.G. Wen, G.J. van Steenbrugge, R.M. Egeler Progress of fundamental research in Wilms' tumor Urol Res 25 1997 223 230
4. D.F. Hayes, R.C. Bast, C.E. Desch Tumor marker grading system a frame work to evaluate clinical utility of tumor markers J Natl Cancer Inst 88 1996 1456 1468
5. H. Kikuchi, Y. Akasaka, T. Nagai Genomic changes in the WT-gene (WT1) in Wilms' tumors and their correlation with histology Am J Pathol 140 1992 781 786
6. R.M. Slater, M.M.A. Mannens Cytogenetics and molecular genetics of Wilms' tumor of childhood Cancer Genet Cytogene 61 1992 111 121
7. M.A. Ghanem, T.H. Van der Kwast, J.C. Den Hollander Expression and prognostic value of WT-1 and EGR-1 proteins in nephroblastoma Clin Cancer Res 6 2000 4265 4271
8. P. Karnik, P. Chen, M. Paris Loss of heterozygosity at chromosome 11p15 in Wilms' tumors identification of two independent regions Oncogene 17 1998 237 240
9. B.E. Mason, P.J. Goodfellow, P.E. Grundy 16q loss of heterozygosity and microsatellite instability in Wilms' tumor J Pediatr Surg 35 2000 891 897
10. S.J. Baker, E.R. Fearon, J.M. Nigro Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas Science 244 1989 217 221
11. B. Klamt, M. Schulze, C. Thate Allele loss in Wilms' tumors of chromosome arms 11q, 16q, and 22q correlates with clinicopathological parameters Genes Chromosome Cancer 22 1998 287 294
12. P.L. Cheah, L.M. Looi, L.L. Chan Immunohistochemical expression of p53 proteins in Wilms' tumors a possible association with the histological prognostic parameter of anaplasia Histopathology 28 1996 49 54
13. P.G. Waber, J. Chen, P.D. Nisen Infrequency of ras, p53, WT1, of Rb gene alterations in Wilms' tumors Cancer 72 1993 373 378
14. C. Lahoti, P. Thorner, D. Malkin Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavorable outcome Am J Pathol 148 1996 1577 1589
15. U.M. Moll, A.G. Ostermeyer, J.-C. Ahomadegbe p53 mediated tumor cell response to chemotherapeutic DNA damage a preliminary study in matched pairs of breast cancer biopsies Hum Pathol 26 1995 1293 1301
16. M.A. Ghanem, T.H. Van der Kwast, J.C. Den Hollander The prognostic significance of apoptosis-associated proteins Bcl-2, Bax and Bcl-X in clinical nephroblastoma Br J Cancer 85 2001 1557 1563
17. K. Tanaka, C. Granata, Y. Wang Apoptosis and bcl-2 oncogene expression in Wilms' tumor Pediatr Surg Int 15 1999 243 247
18. G.G. Re, D.J. Hazen-Martin, R. El-Bahtimi Prognostic significance of Bcl-2 in Wilms' tumors and oncogenic potential of Bcl-Xl in rare tumours cases Int J Cancer 84 1999 192 200
19. M. Nagoshi, M. Tsuneyoshi Expression of proliferating cell nuclear antigen in Wilms' tumors and other pediatrics renal tumors the correlation between histologic classification and proliferative activity J Surg Oncol 55 1994 114 121
20. B. Delahunt, G.J. Farrant, P.B. Bethwaite Assessment of proliferative activity in Wilms' tumor Anal Cell Pathol 7 1994 127 138
21. N.M. Khine, W. Aung, P.D. Sibbons Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index Lab Invest 70 1994 125 129
22. kip1 protein expression in nephroblastoma Clin Cancer Res 10 2004 591 597
23. S. Schmitt, Q. Ren-Qiu, T. Torresani High molecular weight forms of IGF-II ("big-IGF-II") released by Wilms' tumor cells Eur J Endocrin 137 1997 396 401
24. T. Gansler, R. Furlanetto, T.S. Gramling Antibody to type I insulin-like growth factor receptor inhibits growth of Wilms' tumor in culture and in athymic mice Am J Pathol 135 1989 961 966
25. M.H. Little, G. Ablett, P.J. Smith Enhanced expression of insulin-like growth factor II is not a necessary event in Wilms' tumor progression Carcinogenesis 8 1987 865 868
26. S.A. Rogers, G. Ryan, M.R. Hammerman Metanephric transforming growth factor-α is required for renal organogenesis in vitro Am J Physiol 262 1992 F533 F539
27. M.A. Ghanem, T.H. Van Der Kwast, J.C. Den Hollander Expression and prognostic value of epidermal growth factor receptor, transforming growth factor-alpha and C-erbB-2 in nephroblastoma Cancer 92 2001 3120 3129
28. G.E. Fraizer, D.F. Bowen-Pope, A.M. Vogel Production of platelet-derived growth factor by cultured Wilms' tumor cells and fetal kidney cells J Cell Physiol 133 1987 169 174
29. E.G. Skoldenberg, J. Christiansson, B. Sandstedt Angiogenesis and angiogenic growth factors in Wilms' tumor J Urol 165 2001 2274 2279
30. J. Tsutsui, K. Kadomatsu, S. Matsubora A new family of heparin-binding growth/differentiation factors increased midkine expression in Wilms' tumor and other human carcinomas Cancer Res 53 1993 1281 1285
31. M. Takahashi, X. Yang, T. Lavery Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features Cancer Res 62 2002 6598 6605
32. M.L. Kayton, D.H. Rowe, K.M. O'Toole Metastasis correlates with production of vascular endothelial growth factor in a murine model of human Wilms' tumor J Pediatr Surg 34 1999 743 748
33. M.A. Ghanem, G.J. van Steenbrugge, M.K. Sudaryo Expression and prognostic relevance of vascular endothelial growth factor (VEGF) and its receptor (Flt-1) in nephroblastoma J Clin Pathol 56 2003 107 113
34. M.J. Donovan, B. Hempstead, L. Julie-Huber Identification of the neurotrophin receptors p75 and trk in a series of Wilms' tumors Am J Pathol 145 1994 792 801
35. B.A. Eggert, M.A. Grotzer, N. Ikegaki Expression of the neurotrophin receptor TrKB is associated with unfavorable outcome in Wilms' tumor J Clin Oncol 19 2001 689 696
36. E. Séguier-Lipszyc, A. El-Ghoneimi, C. Brinon GDNF expression in Wilms' tumor J Urol 165 2001 2269 2273
37. J. Peringa, W.M. Molenaar, W. Timens Integrins and extracellular matrix-proteins in the different components of the Wilms' tumor Virchows Arch 425 1994 113 119
38. J.F. Talts, E. Aufderheid, L. Sorokin Induction of mouse tenascin expression by a human sarcomatoid Wilms' tumor cell line growing in nude mice Int J Cancer 54 1993 868 874
39. J. Roth, C. Zuber, P. Wagner Presence of the long chain form of polysialic acid of the neural cell adhesion molecule in Wilms' tumor identification of a cell adhesion molecule as an oncodevelopmental antigen and implications for tumor histogenesis Am J Pathol 133 1988 227 240
40. M.A. Ghanem, G.J. Van Steenbrugge, T.H. Van der Kwast Expression and prognostic value of CD44 isoforms in nephroblastoma (Wilms' tumor) J Urol 168 2002 681 686
41. E.C. Douglass, A.T. Look, B. Webber Hyperdiploidy and chromosomal rearrangements define the anaplastic variant of Wilms' tumor J Clin Oncol 4 1986 975 981
42. L.J. Layfield, A.W.S. Ritchie, R. Ehrlich The relationship of deoxyribonucleic acid content to conventional prognostic factors in Wilms' tumor J Urol 142 1989 1040 1043
43. U.G. Falkmer Methodologic sources of errors in image and flow cytometric DNA assessments of the malignancy potential of prostatic carcinoma Hum Pathol 23 1992 360 367
44. M. Udtha, S.-J. Lee, R. Alam Upregulation of c-Myc in WT1-mutant tumors assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors Oncogene 23 2003 3821 3826
45. R. Carachi, G.B.M. Lindop, B.J. Leckie Inactive renin a tumor marker in nephroblastoma J Pediatr Surg 22 1987 278 280
46. G.B.M. Lindop, K. Duncan, D.W.M. Millan Renin gene expression in nephroblastoma J Pathol 161 1990 93 97
47. G.G. Re, M.C. Willingham, G. El-Bahtimi Anaplasia and drug selection-independent overexpression of the multidrug resistant gene, MDR1, in Wilms' tumor Mod Pathol 10 1997 129 136
48. J.E. Sola, K.J. Wojno, W. Dooley P-glycoprotein status of favorable histology Wilms' tumor predicts treatment outcome J Pediatr Surg 29 1994 1080 1083
49. B. Granzen, T. Efferth, U.M.A. Keller Differential expression of the drug resistance markers DNA Topoisomerase IIα and Glutathione S-transferase-π in the histological compartments of Wilms' tumors Anticancer Res 21 2001 771 776